Human Leukocyte Antigen complex
Epigenome-wide and transcriptome-wide analyses reveal gestational diabetes is associated with alterations in the human leukocyte antigen complex
12
Persistent Antigens Hypothesis: The Human Leukocyte Antigen (HLA) Connection
5
Spatial analyzes of HLA data in Rio Grande do Sul, south Brazil: genetic structure and possible correlation with autoimmune diseases
12
Significant Associations of the rs3104413 Single-nucleotide Polymorphism in the HLA Region with Type 1 Diabetes
7
Functional disruption of human leukocyte antigen II in human embryonic stem cell
9
Tri-Allelic Human Leukocyte Antigen (HLA) Protection Against Dementia
6
Neuropathology of SUDEPRole of inflammation, blood-brain barrier impairment, and hypoxia
12
THE PROFILE OF HUMAN LEUKOCYTE ANTIGEN CLASS I IN PATIENTS WITH SCHIZOPHRENIA
8
Evolution of the levels of human leukocyte antigen G (HLA G) in Beninese infant during the first year of life in a malaria endemic area: using latent class analysis
10
The relationship between human leukocyte antigen DP/DQ gene polymorphisms and the outcomes of HCV infection in a Chinese population
7
Activities of stromal and immune cells in HPV-related cancers
18
The biomarkers of immune dysregulation and inflammation response in Parkinson disease
6
Association of human leukocyte antigen-DRB haplotype in multiple sclerosis population of Khuzestan, Iran
7
The role of neoantigen in immune checkpoint blockade therapy
11
Expression of Human Leukocyte Antigen G is associated with Prognosis in Nasopharyngeal Carcinoma
10
Enhanced presentation of MHC class Ia, Ib and class II restricted peptides encapsulated in biodegradable nanoparticles: a promising strategy for tumor immunotherapy
10
Studies with human leukocyte lysosomes Evidence for antilysosome antibodies in lupus erythematosus and for the presence of lysosomal antigen in inflammatory diseases
14
Investigation of Human Leukocyte Antigen (HLA) Class I and II Alleles and Hepatitis C Virus (HCV) Genotypes in Patients Infected with HCV
11
Giant cell arteritis: pathogenic mechanisms and new potential therapeutic targets
12
Differences in systemic adaptive immunity contribute to the ‘frequent exacerbator’ COPD phenotype
10